Sofinnova Partners and Polaris Partners have co-led a CHF 54m series-A round for Noema Pharma, a Swiss clinical-stage company targeting orphan neurological disorders.
GP is investing in the Norway-based marketing technology group via its EUR 540m Edda II fund
Further details are expected to be announced in the coming six weeks, according to a statement
Paris-based manufacturer of construction surface films records annual turnover of more than EUR 30m
Paack, now valued at EUR 1bn, has pledged to be the first delivery service to be 100% emission-free